GlassScriptPhysician profile
Mohsen M Hamza
NPI 1003996844
$23,836.29
in general payments reported to CMS, 2019-2025
73 companies · $5,176 in 2025
The $5,176 reported for 2025 was more than what 86% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,724 · 2020: $1,653 · 2021: $4,252 · 2022: $3,654 · 2023: $3,197 · 2024: $4,180 · 2025: $5,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,296.82 |
| Education | $255.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,391.54 | 2021-2025 | |
| Sk Life Science, INC. | $1,368.88 | 2021-2025 | Xcopri |
| Mdd US Operations, LLC | $1,347.71 | 2019-2025 | Apokyn, Gocovri, Apokyn |
| Allergan, INC. | $793.05 | 2019-2021 | |
| Lilly USA, LLC | $679.05 | 2019-2025 | Emgality, Amyvid, Kisunla |
| Biogen, INC. | $671.21 | 2019-2025 | Vumerity, Skyclarys, Tysabri |
| Harmony Biosciences LLC | $666.55 | 2024-2025 | |
| Lundbeck LLC | $657.16 | 2021-2025 | Vyepti, Rexulti |
| Argenx US, INC. | $649.28 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Ucb, INC. | $601.57 | 2021-2025 | Briviact |
| Genzyme Corporation | $600.46 | 2021-2023 | |
| Merz Pharmaceuticals, LLC | $576.57 | 2021-2025 | Xeomin |
| Amgen INC. | $536.01 | 2024-2025 | Uplizna |
| Eisai INC. | $522.85 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $506.67 | 2020-2025 | Hyqvia, Gammagard |
Show all 73 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohsen Hamza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.